Dr. Kevin Charles Bylund, MD

  • Rochester, NY
  • Radiation oncologist
NPI1497919302PAC ID3476796517
Medicare services, 2024
895
Medicare patients, 2024
153
Part D claims, 2024
195
MIPS score, 2024
90
Hospital affiliations
5
Practice address
1000 South Ave, Rochester, NY 14620
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD

Acute Care Hospital outpatient department · Rochester, New York

See all 9 affiliations

Find Dr. Bylund's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Kevin Charles Bylund is a radiation oncologist in Rochester, New York

Dr. Bylund practices at Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD in Rochester, New York.

Dr. Bylund's NPI, 1497919302, was assigned on July 10, 2008. Dr. Bylund graduated from University of Rochester School of Medicine and Dentistry in 2008. Dr. Bylund holds New York license 269349.

NPI and contact details
Medicare PAC ID
3476796517
NPI enumeration date
July 10, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
44
Medical school graduation
2008

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Kevin Charles Bylund practices at Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD in Rochester, New York

Dr. Bylund's primary practice is Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD, at 1000 South Ave, Rochester, NY 14620.

  • Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD
    1000 South Ave, Rochester, NY 14620

Source: Dmand AI Affiliation Data

Dr. Kevin Charles Bylund is affiliated with 6 sites of care and 3 medical groups

Dr. Bylund's primary practice is Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD in Rochester, New York. Dr. Bylund is also affiliated with Highland Hospital. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Bylund to 4 more hospitals and 2 medical groups, each named with a free account.

See all 9 affiliations for Dr. Bylund

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Kevin Charles Bylund's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bylund practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPDAvailable with a free account
+5 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Bylund practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Kevin Charles Bylund is one of 385 radiation oncologists in New York

Radiation oncology is Dr. Bylund's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Bylund is licensed in New York.

Specialties and state licenses

  • Radiation oncology, New YorkPrimaryLicense 269349 · taxonomy 2085R0001X

Radiation oncologists near Dr. Bylund

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Kevin Charles Bylund billed Medicare for 895 services in 2024

CMS data shows 895 Medicare services from Dr. Bylund across 12 procedure codes in 2024, for 153 Medicare patients. Medicare paid $56,917 for them.

Medicare services, 2024895
Medicare patients153
Paid by Medicare$56,917
Procedure codes12

Dr. Bylund's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 5422024: 71933%
Office and hospital visits
2023: 1882024: 1766%

Where Dr. Bylund's Medicare services took place, 2024

  • In an office334%
  • In a facility86296%

Dr. Bylund compared with the New York median for radiation oncologists, 2024

  • Dr. Bylund
  • New York median
Medicare services
895vs 1,05415% below
Medicare patients
153vs 160Close to median
Part D claims
124vs 363.4 times

Medians across 368 radiation oncologists in New York with Dmand AI profiles that report each measure.

Dr. Bylund's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Bylund

Need commercial claims for Dr. Bylund?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Bylund and other radiation oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Kevin Charles Bylund treated 153 Medicare patients in 2024, average age 74

CMS counts 153 Medicare patients who saw Dr. Bylund in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have cancer, and 74% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bylund's median patient age at 73, with 21% women.

Medicare patients, 2024153
Average age74
Average risk score1.54
Also on Medicaid12%

Dr. Bylund's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Bylund's Medicare patients by sex, 2024

  • Women4328%
  • Men11072%

Chronic conditions among Dr. Bylund's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure74%
  3. High cholesterol61%
  4. Arthritis36%
  5. Chronic kidney disease29%
  6. Diabetes27%
  7. Mood disorders21%
  8. Depression20%

Share of Medicare patients with each condition. A patient can have several.

Dr. Bylund's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women21%
  • Men77%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Kevin Charles Bylund wrote 195 Medicare Part D claims in 2024

In 2024, Dr. Bylund wrote 195 Medicare Part D claims for 83 patients. 97% of them were for generic drugs. CMS names the drug for 124 of them, across 4 drugs with 11 or more claims each, at $1,937 in total drug cost. In 2023, CMS named 128 claims across 3 drugs.

Part D claims, 2024195
Drugs named by CMS4
Total drug cost$1,937
Part D patients83

Dr. Bylund's Part D claims by kind of drug, 2024

  • Generic189 claims97%
  • Brand-name and other6 claims3%

Dr. Bylund's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Bylund's Part D claims, 2024

  • Opioids6%12 of 195 claims
  • Antibiotics10%20 of 195 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1282024: 1243%

Drugs named by CMS: 4 in 2024, 3 in 2023.

See all prescribing by Dr. Bylund

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Kevin Charles Bylund scored 90 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Bylund for performance year 2024, reported as part of a group. Dr. Bylund accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bylund as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Bylund's MIPS scores, performance year 2024

  • 90of 100Final score
  • 68.4of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 81of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find radiation oncologists like Dr. Bylund by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Kevin Charles Bylund received $355 in industry payments from 2017 to 2022

CMS Open Payments shows 3 general payments to Dr. Bylund from 3 drug and device companies from 2017 to 2022. Food and beverage make up the largest share, 100% of the total. Elekta, Inc. paid the most, $235.

General payments to Dr. Bylund by program year, 2017 to 2022

Companies that paid Dr. Bylund the most, 2017 to 2022

Share is of all general payments to this clinician.

See all payments to Dr. Bylund

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Kevin Charles Bylund graduated from University of Rochester School of Medicine and Dentistry

Dr. Bylund graduated from University of Rochester School of Medicine and Dentistry in 2008.

  1. Medical schoolUniversity of Rochester School of Medicine and Dentistry

Source: Dmand AI Professional Profile Data

Sources for Dr. Kevin Charles Bylund's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Kevin Charles Bylund

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Kevin Charles Bylund's NPI number?

Dr. Kevin Charles Bylund's NPI number is 1497919302. It was assigned on July 10, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Kevin Charles Bylund?

Dr. Kevin Charles Bylund is a radiation oncologist in Rochester, New York. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Kevin Charles Bylund practice?

Dr. Bylund practices at 1000 South Ave, Rochester, NY 14620. Dr. Bylund's primary practice is Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD in Rochester, New York. Dmand AI also links Dr. Bylund to 4 hospitals and 2 medical groups.

What is Dr. Kevin Charles Bylund's medical license number?

Dr. Bylund holds New York license 269349.

Which hospitals is Dr. Kevin Charles Bylund affiliated with?

Dr. Bylund is affiliated with Highland Hospital. Dmand AI links Dr. Bylund to 4 more hospitals.

What medical group is Dr. Kevin Charles Bylund part of?

Dr. Bylund is linked to University of Rochester Medical Faculty Group (URMFG). Dmand AI links Dr. Bylund to 2 more medical groups.

Does Dr. Kevin Charles Bylund accept Medicare?

Yes. CMS data shows Dr. Bylund billed Medicare for 895 services in 2024, and Dr. Bylund accepts Medicare assignment.

Does Dr. Kevin Charles Bylund offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Bylund as offering telehealth services.

What is Dr. Kevin Charles Bylund's MIPS score?

Dr. Bylund's MIPS final score for performance year 2024 is 90 out of 100, reported as part of a group.

How many Medicare patients does Dr. Kevin Charles Bylund see?

CMS counts 153 Medicare patients who saw Dr. Bylund in 2024, with an average age of 74.

Show 5 more questionsShow fewer questions

What services does Dr. Kevin Charles Bylund bill to Medicare?

In 2024, Dr. Bylund's most billed Medicare services were radiation oncology (77014), office visit, established patient (99213) and radiation oncology (77300).

Where did Dr. Kevin Charles Bylund go to medical school?

Dr. Bylund graduated from University of Rochester School of Medicine and Dentistry in 2008.

What drugs does Dr. Kevin Charles Bylund prescribe most?

In 2024 Medicare Part D data, Dr. Bylund's most prescribed drugs by claims were Tamsulosin HCl, Bicalutamide and Ciprofloxacin HCl.

Has Dr. Kevin Charles Bylund received payments from drug or device companies?

CMS Open Payments shows $355 in general payments to Dr. Bylund from 3 companies from 2017 to 2022. The largest total came from Elekta, Inc.

How long has Dr. Kevin Charles Bylund been practicing?

Dr. Bylund graduated from medical school in 2008, 18 years ago.

Selling to radiation oncology practices?

See radiation oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)